These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37906202)

  • 1. Disparities in Continuous Glucose Monitor Use Between Children With Type 1 Diabetes Living in Urban and Rural Areas.
    Tilden DR; French B; Datye KA; Jaser SS
    Diabetes Care; 2024 Mar; 47(3):346-352. PubMed ID: 37906202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance.
    Addala A; Maahs DM; Scheinker D; Chertow S; Leverenz B; Prahalad P
    Pediatr Diabetes; 2020 Nov; 21(7):1301-1309. PubMed ID: 32681582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic Disparities in Glycemic Management in Children and Youth With Type 1 Diabetes: A Retrospective Cohort Study.
    Simba S; Von Oettingen JE; Rahme E; Ladd JM; Nakhla M; Li P
    Can J Diabetes; 2023 Dec; 47(8):658-664.e2. PubMed ID: 37481125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine.
    Cobry EC; Reznick-Lipina T; Pyle L; Slover R; Thomas JF; Alonso GT; Wadwa RP
    Diabetes Technol Ther; 2022 Jan; 24(1):67-74. PubMed ID: 34524007
    [No Abstract]   [Full Text] [Related]  

  • 6. Early Racial/Ethnic Disparities in Continuous Glucose Monitor Use in Pediatric Type 1 Diabetes.
    Lai CW; Lipman TH; Willi SM; Hawkes CP
    Diabetes Technol Ther; 2021 Nov; 23(11):763-767. PubMed ID: 34143673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings.
    Mayberry LS; Guy C; Hendrickson CD; McCoy AB; Elasy T
    J Gen Intern Med; 2023 Aug; 38(11):2546-2552. PubMed ID: 37254011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital.
    Fantasia KL; Wirunsawanya K; Lee C; Rizo I
    J Diabetes Sci Technol; 2021 Sep; 15(5):1010-1017. PubMed ID: 33719610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology use and clinical outcomes in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes.
    Baboun D; Solano N; Del Toro V; Alvarez-Salvat R; Granados A; Carrillo-Iregui A
    J Pediatr Endocrinol Metab; 2023 Dec; 36(12):1128-1132. PubMed ID: 37852007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes.
    Sawyer A; Sobczak M; Forlenza GP; Alonso GT
    Diabetes Technol Ther; 2022 Jun; 24(6):409-415. PubMed ID: 35099306
    [No Abstract]   [Full Text] [Related]  

  • 11. A Retrospective Cohort Study of Racial/Ethnic and Socioeconomic Disparities in Initiation and Meaningful Use of Continuous Glucose Monitoring among Youth With Type 1 Diabetes.
    Tremblay ES; Bernique A; Garvey K; Astley CM
    J Diabetes Sci Technol; 2023 Jul; ():19322968231183985. PubMed ID: 37394962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
    Kaushal T; Tinsley LJ; Volkening LK; Turcotte C; Laffel LM
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4197-e4202. PubMed ID: 35948357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center.
    Kanbour S; Jones M; Abusamaan MS; Nass C; Everett E; Wolf RM; Sidhaye A; Mathioudakis N
    Diabetes Care; 2023 Jan; 46(1):56-64. PubMed ID: 36378855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in Continuous Glucose Monitoring Use Among Women of Reproductive Age with Type 1 Diabetes in the T1D Exchange.
    Venkatesh KK; Powe CE; Buschur E; Wu J; Landon MB; Gabbe S; Gandhi K; Grobman WA; Fareed N
    Diabetes Technol Ther; 2023 Mar; 25(3):201-205. PubMed ID: 36753706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes.
    Datye KA; Tilden DR; Parmar AM; Goethals ER; Jaser SS
    Curr Diab Rep; 2021 May; 21(7):22. PubMed ID: 33991264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Equitable Access to Continuous Glucose Monitors for Alabama's Children with Type 1 Diabetes: A Quality Improvement Project.
    Schmitt J; Fogle K; Scott ML; Iyer P
    Diabetes Technol Ther; 2022 Jul; 24(7):481-491. PubMed ID: 35156834
    [No Abstract]   [Full Text] [Related]  

  • 20. Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand.
    Burnside MJ; Williman JA; Davies HM; Jefferies CA; Paul RG; Wheeler BJ; Wiltshire EJ; Anderson YC; de Bock MI
    Lancet Reg Health West Pac; 2023 Feb; 31():100644. PubMed ID: 36419466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.